MAZZA, ELENA BEATRICE
 Distribuzione geografica
Continente #
EU - Europa 165
NA - Nord America 148
AS - Asia 26
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 343
Nazione #
US - Stati Uniti d'America 147
IT - Italia 66
SE - Svezia 62
CN - Cina 14
DE - Germania 10
FR - Francia 9
IE - Irlanda 6
FI - Finlandia 5
GB - Regno Unito 3
IN - India 3
KR - Corea 3
CO - Colombia 2
SG - Singapore 2
A1 - Anonimo 1
BE - Belgio 1
CA - Canada 1
ES - Italia 1
IL - Israele 1
IR - Iran 1
NL - Olanda 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PL - Polonia 1
TW - Taiwan 1
Totale 343
Città #
Ashburn 27
Milan 24
Lawrence 15
Shanghai 14
Princeton 13
New York 12
Marseille 7
Rome 7
Dublin 6
Washington 6
Helsinki 4
Münster 4
Nichelino 4
Gwangjin-gu 3
Bologna 2
Bra 2
Brescia 2
Castelfranco Emilia 2
Castenaso 2
Delhi 2
Floridablanca 2
Lissone 2
London 2
Nuremberg 2
Paris 2
Pavia 2
Seattle 2
Amsterdam 1
Atlanta 1
Auckland 1
Biblis 1
Borsbeek 1
Brighton 1
Bydgoszcz 1
Civitavecchia 1
Como 1
Falkenstein 1
Heidelberg 1
Jerusalem 1
Lappeenranta 1
Los Angeles 1
Madison 1
Madrid 1
Offenbach 1
Pokhara 1
Pune 1
San Jose 1
Santa Clara 1
Taichung 1
Tione di Trento 1
Turin 1
Verona 1
Villanova d'Asti 1
Vimodrone 1
Wotton-under-Edge 1
Totale 200
Nome #
Role of inflammation and metabolism in structural brain integrity in Major Depressive disorder 60
Exploring chemotherapy holiday and drugs re-challenge in advanced pancreatic cancer patients 24
Early regression index (ERI) on MR images as response predictor in esophageal cancer treated with neoadjuvant chemo-radiotherapy: interim analysis of the prospective ESCAPE trial 23
One-year mental health outcomes in a cohort of COVID-19 survivors 21
Long-course temozolomide in aggressive pituitary adenoma: real-life experience in two tertiary care centers and review of the literature 19
Time to CA19-9 nadir: a clue for defining optimal treatment duration in patients with resectable pancreatic ductal adenocarcinoma 18
Nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in metastatic pancreatic adenocarcinoma (PACT-19): a randomised phase 2 trial 18
Insulin resistance disrupts white matter microstructure and amplitude of functional spontaneous activity in Bipolar Disorder 17
Neurofilaments light: Possible biomarker of brain modifications in bipolar disorder 17
null 16
Association between body mass index and subcortical brain volumes in bipolar disorders–ENIGMA study in 2735 individuals 16
Diagnosis of bipolar disorders and body mass index predict clustering based on similarities in cortical thickness - ENIGMA study in 2 436 individuals 16
Consensus guidelines on severe acute pancreatitis 15
Predicting differential diagnosis between bipolar and unipolar depression with multiple kernel learning on multimodal structural neuroimaging 14
Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe 13
High levels of peripheral neuroinflammatory markers are associated with disruption of white matter integrity in patients with major depressive disorder 12
Neoadjuvant chemoradiotherapy in patients with esopageal or esophageal gastric junction cancer 12
A Homer1 gene variant influences brain white matter structure and lithium effects in bipolar disorder 11
New electromechanical substrate abnormalities in high-risk patients with Brugada syndrome 9
White matter integrity and pro-inflammatory cytokines as predictors of antidepressant response in MDD 7
Chemotherapy in elderly patients with pancreatic cancer: Efficacy, feasibility and future perspectives 7
Mega-analysis of association between obesity and cortical morphology in bipolar disorders: ENIGMA study in 2832 participants 4
Erratum: Time course of hypothalamic-pituitary deficiency in adults receiving cranial radiotherapy for primary extrasellar brain tumors (Radiotherapy and Oncology 99 (2011) (23-28)) 2
Totale 371
Categoria #
all - tutte 3.605
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.605


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 0 0 1 0 0 0 0 1
2020/20216 0 0 0 0 2 2 1 1 0 0 0 0
2021/202217 1 0 0 3 0 6 1 1 2 0 0 3
2022/2023145 31 26 8 6 6 27 8 11 11 1 5 5
2023/2024201 12 18 27 23 30 30 7 22 9 18 5 0
Totale 371